Study #2023-0860
A phase I/II study of intraperitoneal Paclitaxel in patients with metastatic appendiceal adenocarcinoma
MD Anderson Study Status
Enrolling
Treatment Agent
Dexamethasone, Diphenhydramine, Famotidine, Paclitaxel
Description
To find the recommended dose of the drug paclitaxel that can be given intraperitoneally (given directly into the abdominal cavity) to participants with metastatic appendiceal adenocarcinoma.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Metastatic Appendiceal Adenocarcinoma, Intraperitoneal Paclitaxel
Study phase:
Physician name:
Beth Helmink
Department:
Surgical Oncology
For general questions about clinical trials:
1-833-922-0089
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.